Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.

Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.

Nanographene oxide (NGO) is a novel nano-wall material that tracks to tumors in vivo, and which, as a consequence of its large surface area, has the capacity to carry a large payload. This study explores the use of anti-HER2 antibody (trastuzumab)-conjugated NGO, radiolabeled with (111)In-benzyl-die...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Cornelissen, B, Able, S, Kersemans, B, Waghorn, P, Myhra, S, Jurkshat, K, Crossley, A, Vallis, K
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Elsevier 2013

Eitemau Tebyg

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
gan: Song, L, et al.
Cyhoeddwyd: (2016)

Imaging DNA damage response (DDR) during oncogenesis
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2013)

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
gan: Kersemans, V, et al.
Cyhoeddwyd: (2005)

In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
gan: Kersemans, V, et al.
Cyhoeddwyd: (2005)

PET and SPECT imaging for the acceleration of anti-cancer drug development
gan: Hillyar, C, et al.
Cyhoeddwyd: (2015)

In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.
gan: Kersemans, V, et al.
Cyhoeddwyd: (2004)

In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT
gan: Kersemans, V, et al.
Cyhoeddwyd: (2004)

Molecular radiotherapy using cleavable radioimmunoconjugates that target eGFR and γH2AX
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2013)

Cell penetrating peptides for in vivo molecular imaging applications.
gan: Kersemans, V, et al.
Cyhoeddwyd: (2008)

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2013)

In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2009)

Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2011)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab.
gan: Patel, N, et al.
Cyhoeddwyd: (2017)

A contorted nanographene shelter
gan: Huang Wu, et al.
Cyhoeddwyd: (2021-08-01)

A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes
gan: Veal, M, et al.
Cyhoeddwyd: (2021)

Synthesis of corannulene-based nanographenes
gan: Muzammil, Ezzah M., et al.
Cyhoeddwyd: (2020)

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer
gan: Baguna-Torres, J, et al.
Cyhoeddwyd: (2020)

Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
gan: Mosley, M, et al.
Cyhoeddwyd: (2015)

Physics and chemistry of graphene : graphene to nanographene /
gan: Enoki, Toshiaki, et al.
Cyhoeddwyd: ([201)

Chiral stacks of a curved nanographene
gan: Zhang, Zhongbo, et al.
Cyhoeddwyd: (2024)

Twisted Nanographenes with Robust Conformational Stability
gan: Penghui Song, et al.
Cyhoeddwyd: (2024-10-01)

Construction of hexabenzocoronene-based chiral nanographenes
gan: Ranran Li, et al.
Cyhoeddwyd: (2023-05-01)

Designer spin order in diradical nanographenes
gan: Yuqiang Zheng, et al.
Cyhoeddwyd: (2020-11-01)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
gan: McLarty, K, et al.
Cyhoeddwyd: (2009)

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2008)

Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.
gan: Kersemans, V, et al.
Cyhoeddwyd: (2011)

Imaging the DNA damage response with PET and SPECT
gan: Knight, J, et al.
Cyhoeddwyd: (2017)

Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.
gan: Kersemans, V, et al.
Cyhoeddwyd: (2011)

Auger electron therapy using In-111-labelled F3 peptide
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2011)

111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2012)

Synthesis and evaluation of an 18F-labeled derivative of F3 for targeting surface expressed nucleolin in cancer and tumor endothelial cells
gan: Vallis, K, et al.
Cyhoeddwyd: (2016)

Mechanochemical synthesis of corannulene-based curved nanographenes
gan: Báti, Gábor, et al.
Cyhoeddwyd: (2023)

The interface of epitaxial nanographene on GaN by PECVD
gan: Zongyao Li, et al.
Cyhoeddwyd: (2019-09-01)

Oxidative cyclo-rearrangement of helicenes into chiral nanographenes
gan: Chengshuo Shen, et al.
Cyhoeddwyd: (2021-05-01)

Solution-processed nanographene distributed feedback lasers
gan: Víctor Bonal, et al.
Cyhoeddwyd: (2019-07-01)

A carbon-fiber sheet resistor for MR-, CT-, SPECT-, and PET-compatible temperature maintenance in small animals
gan: Kersemans, V, et al.
Cyhoeddwyd: (2019)

Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
gan: Yasaman Ardeshirpour, et al.
Cyhoeddwyd: (2018-04-01)

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.
gan: Cornelissen, B, et al.
Cyhoeddwyd: (2005)